FundingWatcher
Home / Investors / Late stage investors / Late stage investors in Cambridge, Massachusetts

Late stage investors in Cambridge, Massachusetts

Updated 16 Nov 2026

Reset

Venture funds

1 funds, by portfolio companies funded in the last 12 months
#FundSectorsStages LeadsFunded, 12 months
1 Founder Collective
Founder Collective backs seed-stage startups, with recent investments including Baselayer, WHOOP and Ownwell.
Cambridge, United States
Artificial intelligence, Commerce Seed, Early stage venture, Late stage venture 6% 2

Table 1. Late stage investors in Cambridge, Massachusetts: venture capital and micro VC funds ranked by companies whose Series C and later round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.

Late stage investors in Cambridge, Massachusetts
One-time CSV
  • 51 firms, 46 with a website
  • 30 firm email addresses
  • 28 phone numbers
  • CRM-ready CSV, 15 columns
  • Download right after payment
With partner contacts
Compiled to order
  • The full list, plus the people who invest
  • Up to 2 partners per firm, compiled to order
  • Name, job title and LinkedIn where found
  • Verified direct email per person
  • List CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

investors-stage-late-stage-investors-cambridge-massachusetts.csv51 rows × 15 columns
InvestorTypeLocationEmailPhone
Atlas VentureVenture capital firmCambridge, United States•••@atlasventure.com857 20•••
Founder CollectiveVenture capital firmCambridge, United States•••@foundercollective.com(617) •••
F-PrimeVenture capital firmCambridge, United States•••@fprimecapital.com
AccompliceFamily officeCambridge, United States•••@accomplice.co617-58•••
Sanofi VenturesCorporate venture armCambridge, United States•••@gmail.com+1 617•••
HealthCare VenturesVenture capital firmCambridge, United States•••@hcven.com617-25•••
Flint CapitalVenture capital firmCambridge, United States•••@flintcap.com
Mission BioCapitalVenture capital firmCambridge, United States•••@missionbiocapital.com+1 617•••

8 rows of the CSV in 5 of its 15 columns, email and phone masked.

investors-stage-late-stage-investors-cambridge-massachusetts-contacts.csvUp to 2 verified partners per firm × 7 columns
FirmPersonTitleVerified emailLinkedIn
Atlas VentureB••• B•••Partnerb•••@atlasventure.comIn the CSV
Founder CollectiveA••• H•••General Partnera•••@foundercollective.comIn the CSV
F-PrimeS••• J•••General Partner and Co-Founder, Investing in AI Native Software s•••@fprimecapital.comIn the CSV
AccompliceS••• A••• D•••Operating Partners•••@accomplice.coIn the CSV
Flagship PioneeringI••• M•••General Partneri•••@flagshippioneering.comIn the CSV

5 verified partner contact rows from organizations on this list, names and emails masked.

51
Investors
30
With email
28
With phone
10
Active in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Late stage investors in Cambridge, Massachusetts

30 of 51, most investments first
30 rows
# Investor Type Location Invests in Latest portfolio companies Funded, 12 months Investments Lead Exits Email Phone LinkedIn
1 Atlas Venture Venture capital firm Cambridge, United States Health care, Biotech Diagonal Therapeutics 1 638 179 199 •••@atlasventure.com 857 20••• In the CSV
2 Founder Collective Venture capital firm Cambridge, United States Artificial intelligence, Commerce Baselayer, WHOOP, Ownwell 5 543 35 161 •••@foundercollective.com (617) ••• In the CSV
3 F-Prime Venture capital firm Cambridge, United States Health care, Fintech T-Therapeutics, Albert Invent, Immuneel Therapeutics 4 540 133 113 •••@fprimecapital.com In the CSV
4 Accomplice Family office, Venture capital firm Cambridge, United States Fintech, Artificial intelligence Veera 1 386 101 88 •••@accomplice.co 617-58••• In the CSV
5 Flagship Pioneering Venture capital firm Cambridge, United States Biotech, Health care Inari, Prologue Medicines, Quotient Therapeutics 288 104 72 617-86••• In the CSV
6 SR One Venture capital firm Cambridge, United States Biotech, Health care Asceneuron 214 69 69 (610) ••• In the CSV
7 CVP Management Micro VC fund, Venture capital firm Cambridge, United States Hardware, Commerce TimeTrade, Podium Data, FamilyID 152 16 37 In the CSV
8 Sanofi Ventures Corporate venture arm Cambridge, United States Biotech, Health care i2o Therapeutics, Tisento Therapeutics, NGI 119 31 28 •••@gmail.com +1 617••• In the CSV
9 Johnson & Johnson Innovation Corporate venture arm Cambridge, United States Health care, Biotech ONL Therapeutics, Flindr Therapeutics, Asgard Therapeutics 118 39 26 In the CSV
10 HealthCare Ventures Venture capital firm Cambridge, United States 109 22 36 •••@hcven.com 617-25••• In the CSV
11 Flint Capital Venture capital firm Cambridge, United States Artificial intelligence, Hardware Bluebricks, Antidote Health, Nokod Security 101 36 18 •••@flintcap.com In the CSV
12 Clarus Ventures Venture capital firm Cambridge, United States Biotech, Health care ESBATech 88 38 34 888-75••• In the CSV
13 Mission BioCapital Venture capital firm Cambridge, United States Biotech, Health care Circle Pharma, Cloverleaf Bio, Integrated Biosciences 4 85 17 19 •••@missionbiocapital.com +1 617••• In the CSV
14 Safar Partners Private equity firm, Venture capital firm Cambridge, United States Biotech, Health care Gelmedix 1 85 17 7 •••@safar.partners (646) ••• In the CSV
15 Romulus Capital Venture capital firm Cambridge, United States Health care, Fintech Albiware, Lora DiCarlo, Placester 71 34 15 •••@romuluscap.com +1 888••• In the CSV
16 Link Ventures Venture capital firm Cambridge, United States Commerce, Fintech Enlaye, Blitzy, Dono 3 71 27 6 •••@linkventures.com In the CSV
17 Fairhaven Capital Partners Venture capital firm Cambridge, United States Hardware, Cybersecurity Pwnie Express, Py, ShopWell 71 20 24 •••@fairhavencapital.com (617) ••• In the CSV
18 HubSpot Ventures Corporate venture arm Cambridge, United States Artificial intelligence, Commerce Agency AI, Artisan AI, doola 64 12 8 •••@hubspot.com +1 888••• In the CSV
19 Koa Labs Venture capital firm Cambridge, United States Artificial intelligence, Health care OncoveryCare, Hopara, AskFora 50 0 6 •••@koalab.com +1 603••• In the CSV
20 Rhapsody Venture Partners Venture capital firm Cambridge, United States Hardware, Artificial intelligence Polaris Electro-Optics 1 46 25 2 •••@rhapsodyvp.com In the CSV
21 SpringTide Ventures Venture capital firm Cambridge, United States Health care, Artificial intelligence Prolucent Health, Leash Biosciences, Binkey 43 12 6 801-82••• In the CSV
22 Tectonic Ventures Venture capital firm Cambridge, United States Artificial intelligence, Hardware Marveri, Humatics, OmniML 43 3 4 In the CSV
23 Waterline Ventures Venture capital firm Cambridge, United States Health care, Artificial intelligence Manifold 1 41 10 8 •••@waterlineventures.com (857) ••• In the CSV
24 Causeway Media Partners Private equity firm, Venture capital firm Cambridge, United States Commerce Freeletics, SquadLocker, SportsEngine 34 12 9 •••@causewaymp.com 617.85••• In the CSV
25 Biogen Venture capital firm Cambridge, United States Biotech, Health care Autobahn Therapeutics 32 9 19 +1 781••• In the CSV
26 Action Potential Venture Capital Venture capital firm Cambridge, United States Health care Presidio Medical 30 5 3 (888) ••• In the CSV
27 LSP BioVentures Venture capital firm Cambridge, United States Biotech, Health care Innovative Molecules, Luxendo, Affectis Pharmaceuticals 29 14 18 •••@yfcip.pbz (781) ••• In the CSV
28 Rivas Capital Venture capital firm Cambridge, United States Artificial intelligence, Biotech ReviveMed, Comgy 25 5 5 (857) ••• In the CSV
29 Remiges Ventures Venture capital firm Cambridge, United States Biotech, Health care Kupando 1 24 15 0
30 Yonjin Venture Venture capital firm Cambridge, United States 24 5 7 •••@yjventure.com (657) •••

Table 2. Late stage investors in Cambridge, Massachusetts: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 51.

Most active in the last 12 months

By portfolio companies funded
#InvestorLocation Funded, 12 monthsPortfolioLatest
1 Founder Collective Cambridge, United States 5 119 Baselayer, WHOOP, Ownwell
2 F-Prime Cambridge, United States 4 75 T-Therapeutics, Albert Invent, Immuneel Therapeutics
3 Mission BioCapital Cambridge, United States 4 8 Circle Pharma, Cloverleaf Bio, Integrated Biosciences
4 Link Ventures Cambridge, United States 3 14 Enlaye, Blitzy, Dono
5 Rhapsody Venture Partners Cambridge, United States 1 3 Polaris Electro-Optics
6 Remiges Ventures Cambridge, United States 1 3 Kupando
7 Safar Partners Cambridge, United States 1 4 Gelmedix
8 Accomplice Cambridge, United States 1 47 Veera
9 Atlas Venture Cambridge, United States 1 47 Diagonal Therapeutics
10 Waterline Ventures Cambridge, United States 1 4 Manifold

Table 3. Late stage investors in Cambridge, Massachusetts: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Latest rounds in their portfolios

Newest first
10 rows
Company What they do Sector Location Last round Amount Date Total raised Investors on this list Employees Founded
T-Therapeutics T-Therapeutics develops T cell receptor therapies, spun off from the University of Cambridge. Biotech Cambridge, United Kingdom Series B $133.0M 2026-11-05 $224.6M F-Prime 51 to 100 2022
Albert Invent Albert Invent builds an AI platform that supports chemistry research and development for scientific and industrial users. Artificial intelligence Oakland, United States Series B $55.0M 2026-10-13 $105.0M F-Prime 101 to 250 2022
Baselayer Baselayer automates risk assessment and fraud detection for financial and government institutions. Artificial intelligence New York, United States Series A $35.0M 2026-09-22 $82.0M Founder Collective 51 to 100 2024
Circle Pharma Circle Pharma develops bioavailable macrocyclic peptide therapeutics that target protein-protein interactions. Biotech South San Francisco, United States Series E $92.5M 2026-09-16 $300.0M Mission BioCapital 11 to 50 2012
Polaris Electro-Optics Polaris Electro-Optics develops integrated photonics for communications and computation. Hardware Broomfield, United States Series B $50.0M 2026-09-15 $63.2M Rhapsody Venture Partners 11 to 50 2021
Cloverleaf Bio Cloverleaf Bio develops an RNA therapeutic platform for oncology. Biotech New Haven, United States Seed $33.0M 2026-09-08 $33.0M Mission BioCapital 1 to 10 2023
Integrated Biosciences Integrated Bio develops multimodal biological datasets and AI for drug discovery against age-related diseases. Artificial intelligence Redwood City, United States Series A $68.4M 2026-08-05 $85.6M Mission BioCapital 11 to 50 2022
Enlaye Enlaye provides a cloud-based platform for writing, negotiating, and collaborating on contracts. Artificial intelligence Boston, United States Seed $5.0M 2026-06-10 $6.7M Link Ventures 1 to 10 2023
Immuneel Therapeutics Immuneel Therapeutics develops cell and gene therapies to treat cancer. Health care Bangalore, India Series B $10.5M 2026-06-08 $37.6M F-Prime 51 to 100 2018
Blitzy Blitzy automates custom software development using generative AI technology. Artificial intelligence Boston, United States Series A $200.0M 2026-05-05 $210.4M Link Ventures 101 to 250 2023

Table 4. Late stage investors in Cambridge, Massachusetts: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.

Portfolio sectors

Portfolio sectorsCompaniesShare
Software 328 73%
Health care 99 22%
Artificial intelligence 74 17%
Fintech 61 14%
Hardware 60 13%
Biotech 57 13%
Commerce 43 10%
Cybersecurity 35 8%
Education 19 4%
Energy 1 0%

Table 5. Late stage investors in Cambridge, Massachusetts: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Investment stages

Table 6. Late stage investors in Cambridge, Massachusetts by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.

Founded

FoundedInvestorsShare
2020s 4 9%
2010s 18 40%
2000s 12 27%
1990s 2 4%
1980s 5 11%
1970s 2 4%

Table 7. Late stage investors in Cambridge, Massachusetts by founding decade. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many late stage investors in Cambridge, Massachusetts are on the list?
51, in the file dated 16 November 2026. 10 of them invested in a company whose most recent round falls in the last 12 months.
How many have an email address?
30 of the 51 carry an email address in the download and 28 a phone number.
What does the CSV contain?
One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
How much does the list cost?
$29 one-time for all 51 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV with 51 rows, 30 firm email addresses and 28 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 22 of the 30 are inboxes such as info@ or contact@. No partner names.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Late stage investors in Cambridge, Massachusetts: 51 rows, CSV, $29 one-time.

At once: the CSV with 51 rows, 30 firm email addresses and 28 phone numbers, on the page after payment and by mail.

The emails are the address a firm publishes: 22 of the 30 are inboxes such as info@ or contact@. No partner names.

Columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.

With partner contacts: $199 one-time. List CSV right after payment; up to 2 verified partner emails per firm compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Investor types in Cambridge

Other stages in Cambridge

Late stage investors elsewhere

Cite: FundingWatcher, 51 late stage investors in Cambridge, Massachusetts, 16 November 2026. https://fundingwatcher.com/investors/stage/late-stage-investors/cambridge-massachusetts/